School of Psychology and Psychiatry, Monash University, Clayton, Victoria, Australia.
Psychooncology. 2014 Jun;23(6):642-9. doi: 10.1002/pon.3462. Epub 2013 Dec 18.
The primary aim of this retrospective study was to determine levels of psychological distress and quality of life (QoL) immediately prior to allogeneic stem cell transplantation. The secondary aim was to examine the demographic, medical and psychosocial factors that were correlated with various QoL domains at this stage of treatment.
A series of measures was completed by 122 allograft patients as part of routine psychological assessment at the treating hospital prior to undergoing the transplant. These included the Mental Adjustment to Cancer Scale, the Brief Symptom Inventory-18 and the World Health Organisation Quality of Life-BREF. Demographic and medical data were also extracted.
In this study, 12% and 14% of the sample experienced significant levels of depressive and anxiety symptoms, respectively. Half of the sample reported impaired physical QoL, whereas approximately 40% reported poor psychological and social QoL. Besides relationship status, the limited number of demographic (age and gender) and medical factors (disease status) tested did not contribute significantly to reported QoL. After controlling for medical and demographic factors, weaker Fighting Spirit and higher levels of depression (trend towards significance) were associated with poorer physical and social QoL.
The association among psychological distress, coping responses and QoL indicates that poor psychosocial functioning pre-transplant renders an increased likelihood of experiencing impaired QoL across various dimensions. It thus seems important that psychologically vulnerable patients are identified early in the treatment process. If psychosocial adjustment were improved, patients may experience better QoL pre-transplant with a potential subsequent influence on post-transplant outcomes.
本回顾性研究的主要目的是确定异基因干细胞移植前患者的心理困扰和生活质量(QoL)水平。次要目的是检查与治疗阶段各 QoL 维度相关的人口统计学、医学和社会心理因素。
在接受移植前,122 名同种异体移植患者在治疗医院完成了一系列措施,包括癌症心理调整量表、简明症状量表-18 和世界卫生组织生活质量量表-BREF。还提取了人口统计学和医学数据。
在这项研究中,12%和 14%的样本分别经历了显著水平的抑郁和焦虑症状。样本的一半报告身体 QoL 受损,而大约 40%的报告心理和社会 QoL 较差。除了关系状况外,测试的少数人口统计学(年龄和性别)和医学因素(疾病状况)对报告的 QoL 没有显著贡献。在控制医学和人口统计学因素后,较弱的战斗精神和更高水平的抑郁(有显著趋势)与较差的身体和社会 QoL 相关。
心理困扰、应对反应和 QoL 之间的关联表明,移植前较差的社会心理功能增加了在多个维度上经历受损 QoL 的可能性。因此,似乎很重要的是,要在治疗过程早期识别出心理脆弱的患者。如果心理社会调整得到改善,患者可能在移植前体验到更好的 QoL,并可能对移植后的结果产生后续影响。